Last reviewed: June 28, 2026
Last updated: June 28, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Ozempic (semaglutide) carries FDA approval specifically for type 2 diabetes management, not weight loss—yet millions use it off-label for weight reduction because clinical trials show significant metabolic benefits. Understanding the distinction between approved indications and real-world applications helps patients make informed decisions about their treatment path.
Ozempic's FDA Approval Status and Official Use
The FDA approved Ozempic in 2017 for improved glycemic control in adults with type 2 diabetes. The approval focused on blood sugar regulation through GLP-1 receptor activation, a mechanism that increases insulin secretion when glucose levels rise. Despite this diabetes-specific indication, prescribers began observing significant weight loss as a secondary effect in clinical practice and trial data.
Weight loss applications of semaglutide later received separate FDA approval under the brand name Wegovy in 2021, designed specifically for chronic weight management in adults with obesity or overweight with weight-related conditions. This distinction matters because Ozempic's labeling technically limits its indication to diabetes, while Wegovy targets weight loss directly. However, both contain identical active pharmaceutical ingredients and deliver comparable metabolic results through the same GLP-1 pathway.
How Semaglutide Works in the Body
Semaglutide mimics glucagon-like peptide-1, a natural hormone that regulates appetite, blood sugar, and gastric emptying. When you inject or take semaglutide orally, it binds to GLP-1 receptors in the brain's satiety centers, triggering feelings of fullness that persist for hours. This mechanism reduces overall calorie intake without requiring willpower-driven restriction, making sustained weight loss more achievable for many patients.
The drug also slows stomach emptying, meaning food stays in your digestive tract longer and nutrient absorption feels more complete with smaller portions. Over 68 weeks in pivotal trials, adults using semaglutide lost an average of 15% of their starting body weight, compared to 2-3% with lifestyle changes alone. This metabolic shift addresses obesity at the hormonal level rather than treating it as purely a behavioral problem.
Off-Label Use, Clinical Evidence, and Patient Access
When doctors prescribe a medication for an approved indication's secondary benefit—or for a condition outside its original approval—this is called off-label use and is legal and common in U.S. medicine. Ozempic prescribed for weight loss falls into this category, supported by robust clinical data showing efficacy but technically outside the drug's labeled indication. Many insurers restrict coverage for off-label semaglutide weight loss, which is why direct-pay options have become essential for patients seeking this therapy.
PlexusDx offers compounded semaglutide injection from licensed 503A pharmacies, starting at $149 per month with no insurance required and no membership fees. Patients can access treatment across all 50 states with HSA/FSA eligibility, sidestepping insurance authorization delays. The Precision Peptide Genetic Test (an add-on after first month) maps 14 metabolic pathways and 49 peptides—including key GLP-1R and GIPR variants—to personalize therapy and predict response likelihood before committing to long-term treatment.
Compounded Semaglutide vs. Brand-Name Options
Brand-name Ozempic and Wegovy are produced in FDA-regulated facilities and manufactured at massive scale, but they carry significant costs and insurance barriers. Compounded semaglutide from 503A pharmacies follows identical USP (United States Pharmacopeia) standards for purity, potency, and sterility, ensuring equivalent therapeutic quality at a fraction of the price. PlexusDx partners exclusively with licensed 503A compounding pharmacies—never 503B—to maintain the highest safety and quality thresholds.
The cost difference is substantial: brand-name semaglutide can exceed $900 per month without insurance, while PlexusDx's compounded injection remains flat at $149–$189 per month across all commitment tiers. Your dose may need to go up as your body's response plateaus, but your price won't increase with dose adjustments. This pricing transparency eliminates the anxiety patients feel when titrating GLP-1 therapy.
Personalized Therapy Through Genetic Insights
Not everyone responds equally to semaglutide—genetic variation in GLP-1 receptor structure, GIPR signaling, and appetite-regulation pathways like FTO and MC4R influence how effectively the drug works for each person. The PlexusDx Precision Peptide Genetic Test analyzes key variants (rs6923761 in GLP1R, rs1800437 in GIPR, rs9939609 in FTO, rs17782313 in MC4R) plus 150+ additional genetic insights across 14 metabolic pathways. This testing reveals whether your body's peptide signaling favors GLP-1 response or whether alternative compounds like tirzepatide might serve you better.
Genetic testing enables precision weight loss rather than trial-and-error prescribing. A patient with certain GLP1R variants may achieve superior results with higher semaglutide doses, while another with GIPR-dominant signaling might benefit more from dual-compound therapy like PlexusDx's GLP-Squared injection. Testing costs $99 as an add-on after your first month of treatment, transforming a guess into actionable medical science.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is Ozempic actually approved by the FDA for weight loss?
No. Ozempic received FDA approval for type 2 diabetes management in 2017. Weight loss use is off-label, though supported by clinical evidence. Wegovy (semaglutide's separate brand name) is FDA-approved specifically for chronic weight management. Both medications contain identical active ingredients.
How much weight can I realistically expect to lose with semaglutide?
Clinical trials show average weight loss of 15% of starting body weight over 68 weeks—roughly 3–4 times greater than diet and exercise alone. Individual results vary based on genetics, adherence, and baseline metabolism. PlexusDx's Precision Peptide Genetic Test helps predict your likely response range.
Why is compounded semaglutide so much cheaper than brand-name Ozempic or Wegovy?
Compounded medications bypass massive marketing budgets and patent protections that drive brand-name pricing. PlexusDx's compounded semaglutide injection starts at $149/month from licensed 503A pharmacies with identical USP standards for purity and potency. Your dose may increase, but your price remains flat.
Is compounded semaglutide as safe and effective as the brand name?
Licensed 503A compounding pharmacies follow FDA guidelines and USP standards ensuring quality equivalent to brand medications. PlexusDx exclusively partners with 503A facilities—never 503B—maintaining the highest safety thresholds. Compounded and brand medications contain the same active pharmaceutical ingredient and deliver identical clinical results.
How does the Precision Peptide Genetic Test help me choose the right GLP-1 therapy?
The test analyzes your GLP1R, GIPR, FTO, and MC4R variants plus 146 additional genetic insights across 14 metabolic pathways to predict which GLP-1 compound—semaglutide, tirzepatide, or dual-compound therapy—will work best for your body's peptide signaling. This $99 add-on transforms guesswork into personalized precision medicine.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Understanding the Side Effects of Ozempic: A Comprehensive Guide
Does Zepbound Help Burn Fat? Exploring Its Role in Weight Loss